ClinicalTrials.Veeva

Menu

Human Gut Microbiota and microRNA Expression

A

Air Force Military Medical University of People's Liberation Army

Status

Unknown

Conditions

Gut Microbiota
microRNA

Treatments

Dietary Supplement: stachyose
Dietary Supplement: Maltodextrin

Study type

Interventional

Funder types

Other

Identifiers

NCT05392348
KY20212094-C-1

Details and patient eligibility

About

In this study, stachyose was used as an intervention factor. We will evaluate changes in fecal gut microbiota and miRNA expression profiles in subjects under stachyose intervention

Full description

In the stachyose intervention group, each person in the stachyose intervention group took 5 g of stachyose daily before breakfast, and the administration method was 100 ml of drinking water dissolved and taken orally for two months. Each person in the placebo control group took the same amount of maltodextrin daily. Stool samples of the subjects were collected weekly.

Enrollment

36 estimated patients

Sex

All

Ages

18 to 30 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • healthy human

Exclusion criteria

  • people who need intake antibiotics,probiotics or its product

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

36 participants in 2 patient groups, including a placebo group

Normal Control group
Placebo Comparator group
Description:
Subjects with maltodextrin as intervention,5g/kg·bw/day.
Treatment:
Dietary Supplement: Maltodextrin
Stachyose intervention group
Experimental group
Description:
Subjects with stachyose as intervention,5g/kg·bw/day.
Treatment:
Dietary Supplement: stachyose

Trial contacts and locations

1

Loading...

Central trial contact

Chao Guo

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems